FAM
KYMR icon

Fred Alger Management’s Kymera Therapeutics KYMR Stock Holding History

Fred Alger Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,639
Closed -$1.45M – 486
2025
Q4 		$1.45M Buy
+18,639
New +$1.26M 0.01% 332
2024
Q4 		– Sell
-18,141
Closed -$859K – 445
2024
Q3 		$859K Buy
+18,141
New +$801K ﹤0.01% 353
2022
Q1 		– Sell
-93,049
Closed -$5.91M – 527
2021
Q4 		$5.91M Hold
93,049
– – 0.01% 285
2021
Q3 		$5.47M Buy
+93,049
New +$5.39M 0.01% 283

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Fred Alger Management's KYMR Position: Q1 2026 in Review

Fred Alger Management sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 18,639 shares — an estimated $1.45M sold.

Fred Alger Management first reported a position in KYMR in Q3 2021 and held it in 4 quarters. The position peaked at $5.91M in Q4 2021. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Fred Alger Management reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Fred Alger Management sold 18,639 Kymera Therapeutics shares in Q1 2026, an estimated $1.45M.
  • Fred Alger Management first reported a position in Kymera Therapeutics in Q3 2021 and held it in 4 quarters.
  • Fred Alger Management's Kymera Therapeutics position peaked at $5.91M in Q4 2021.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.